Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. I-Mab
  6. News
  7. Summary
    IMAB   US44975P1030

I-MAB

(IMAB)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 09/17 03:11:50 pm
75.575 USD   +10.91%
09/15China's biotech sector comes of age with big licensing deals, global ambitions
RE
09/13I-MAB : Added to FTSE ESG Index Series
PR
09/02I-MAB : Added to FTSE Russell Global Equity Index Series
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about I-MAB
09/13I-MAB : Added to FTSE ESG Index Series
PR
09/02I-MAB : Added to FTSE Russell Global Equity Index Series
PR
09/01I MAB : HC Wainwright Adjusts I-Mab's Price Target to $95 from $75, Keeps Buy Ra..
MT
08/31I MAB : H1 Loss Widens
MT
08/31I MAB : Provides Business and Corporate Updates and Reports Financial Results fo..
PU
08/31I-Mab Announces Consolidated Earnings Results for the Six Months Ended June 3..
CI
08/30I-MAB : Announces Upcoming Participation at September Conferences
PR
08/27I MAB : Announces Upcoming Participation at September Conferences
PU
08/20I MAB : Announces Establishment of Environmental, Social and Governance Committe..
PU
08/20I-Mab Announces Committee Appointments
CI
08/19I-MAB : Announces Establishment of Environmental, Social and Governance Committe..
PR
08/17I-MAB : to Provide Business and Corporate Updates and Report Financial Results f..
PR
08/12I MAB : Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Ant..
PU
08/11I MAB : Says Plonmarlimab Demonstrated Therapeutic Potential in Severe COVID-19
MT
08/11I-MAB : Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Ant..
PR
More most relevant news
All news about I-MAB
09/15China's biotech sector comes of age with big licensing deals, global ambition..
RE
09/13I-MAB : Added to FTSE ESG Index Series
PR
09/02I-MAB : Added to FTSE Russell Global Equity Index Series
PR
09/01I MAB : HC Wainwright Adjusts I-Mab's Price Target to $95 from $75, Keeps Buy Ra..
MT
08/31I MAB : H1 Loss Widens
MT
08/31I MAB : Provides Business and Corporate Updates and Reports Financial Results fo..
PU
08/31I-Mab Announces Consolidated Earnings Results for the Six Months Ended June 3..
CI
08/30I-MAB : Announces Upcoming Participation at September Conferences
PR
08/27I MAB : Announces Upcoming Participation at September Conferences
PU
08/20I MAB : Announces Establishment of Environmental, Social and Governance Committe..
PU
More news
News in other languages on I-MAB
08/31La perte d'I-Mab H1 se creuse
More news
Analyst Recommendations on I-MAB
09/01I MAB : HC Wainwright Adjusts I-Mab's Price Target to $95 from $75, Keeps Buy Ra..
MT
07/13I MAB : Cantor Fitzgerald Adjusts I-Mab PT to $95 From $90, Maintains Overweight..
MT
06/10I MAB : Cantor Fitzgerald Adjusts I-Mab's Price Target to $90 From $76, Maintain..
MT
06/07I MAB : Piper Sandler Adjusts I-Mab PT to $90 From $75, Maintains Overweight Rat..
MT
06/02I MAB : Daiwa Securities Initiates Coverage on I-Mab With Buy Rating
MT
More recommendations
Press releases
09/13I-MAB : Added to FTSE ESG Index Series
PR
09/02I-MAB : Added to FTSE Russell Global Equity Index Series
PR
08/31I MAB : Provides Business and Corporate Updates and Reports Financial Results fo..
PU
08/30I-MAB : Announces Upcoming Participation at September Conferences
PR
08/27I MAB : Announces Upcoming Participation at September Conferences
PU
More press releases
Upcoming event on I-MAB
09/23/21